OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $952,000 | -55.7% | 233,793 | -53.7% | 0.02% | -46.8% |
| Q1 2022 | $2,149,000 | -89.3% | 504,505 | -76.5% | 0.05% | -86.8% |
| Q4 2021 | $20,128,000 | -66.0% | 2,150,404 | 0.0% | 0.36% | -56.8% |
| Q3 2021 | $59,265,000 | -1.5% | 2,150,404 | 0.0% | 0.82% | -15.0% |
| Q2 2021 | $60,168,000 | -15.7% | 2,150,404 | 0.0% | 0.97% | -10.2% |
| Q1 2021 | $71,350,000 | -31.0% | 2,150,404 | 0.0% | 1.08% | -25.5% |
| Q4 2020 | $103,391,000 | – | 2,150,404 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |